Getinge AB (publ) (GNGBY)
OTCMKTS · Delayed Price · Currency is USD
22.61
+0.02 (0.07%)
At close: Dec 12, 2025
Getinge AB Revenue
Getinge AB had revenue of 8.23B SEK in the quarter ending September 30, 2025, with 4.52% growth. This brings the company's revenue in the last twelve months to 35.85B, up 6.74% year-over-year. In the year 2024, Getinge AB had annual revenue of 34.76B with 9.21% growth.
Revenue (ttm)
35.85B SEK
Revenue Growth
+6.74%
P/S Ratio
1.62
Revenue / Employee
3.04M SEK
Employees
11,791
Market Cap
6.17B USD
Revenue Chart
* This company reports financials in SEK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 34.76B | 2.93B | 9.21% |
| Dec 31, 2023 | 31.83B | 3.54B | 12.49% |
| Dec 31, 2022 | 28.29B | 1.24B | 4.60% |
| Dec 31, 2021 | 27.05B | -2.77B | -9.29% |
| Dec 31, 2020 | 29.82B | 3.26B | 12.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 196.17M |
| Elite Pharmaceuticals | 122.89M |
| Zomedica | 29.45M |
| Silence Therapeutics | 25.83M |
| OpGen | 9.00M |
| Northwest Biotherapeutics | 937.00K |
Getinge AB News
- 7 weeks ago - Getinge AB (GNGBY) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amid Tariff Challenges - GuruFocus
- 7 weeks ago - Q3 2025 Getinge AB Earnings Call Transcript - GuruFocus
- 7 weeks ago - Getinge AB (publ) (GNGBY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Getinge AB (GNGBF) Reports Strong Q3 Performance with Revenue Growth - GuruFocus
- 7 weeks ago - Getinge AB (publ) 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 7 weeks ago - Getinge AB Non-GAAP EPS of SEK 2.42, revenue of SEK 8.23B; reaffirms FY outlook - Seeking Alpha
- 7 weeks ago - Medical gear maker Getinge tops core profit estimates in third quarter - Reuters
- 5 months ago - Getinge AB (publ) (GNGBF) Q2 2025 Earnings Call Transcript - Seeking Alpha